CAPS2 (Calcyphosine 2) (average methylation 14%, p = 0.005) is overexpressed in lung cancer, where it promotes cell proliferation, migration, invasion, and metastasis by activating the ERK/MAPK and AKT signaling pathways [62]. Here, CAPS2 is linked to lung carcinoma.